ResMed Inc.
228.56
-1.70 (-0.74%)
At close: Jan 14, 2025, 3:59 PM
228.83
0.12%
After-hours Jan 14, 2025, 07:00 PM EST
undefined%
Bid 210
Market Cap 33.55B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 7.53
PE Ratio (ttm) 30.35
Forward PE n/a
Analyst Hold
Ask 233.99
Volume 481,989
Avg. Volume (20D) 900,745
Open 231.81
Previous Close 230.26
Day's Range 227.68 - 232.07
52-Week Range 168.29 - 260.49
Beta undefined

About RMD

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use i...

Sector Healthcare
IPO Date Jun 2, 1995
Employees 9,980
Stock Exchange NYSE
Ticker Symbol RMD

Analyst Forecast

According to 12 analyst ratings, the average rating for RMD stock is "Hold." The 12-month stock price forecast is $250, which is an increase of 9.38% from the latest price.

Buy 33.33%
Hold 58.33%
Sell 8.33%
Stock Forecasts

Next Earnings Release

ResMed Inc. is scheduled to release its earnings on Jan 30, 2025, after market closes.
Analysts project revenue of $1.27B, reflecting a 9.20% YoY growth and earnings per share of 2.31, making a 22.87% increase YoY.
3 weeks ago · Source
-2.57%
ResMed shares are trading lower after rival Eli Li... Unlock content with Pro Subscription
2 months ago · Source
+7.12%
ResMed shares are trading higher after the company reported better-than-expected Q1 financial results.